আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

ceva santé animale - spectinomycin dihydrochloride pentahydrate - oral solution - 50 milligram(s)/millilitre - spectinomycin

কানাডা - ইংরেজি - Health Canada

verity pharmaceuticals inc. - fosfomycin (fosfomycin sodium) - powder for solution - 2g - fosfomycin (fosfomycin sodium) 2g - urinary anti-infectives

কানাডা - ইংরেজি - Health Canada

verity pharmaceuticals inc. - fosfomycin (fosfomycin sodium) - powder for solution - 4g - fosfomycin (fosfomycin sodium) 4g - urinary anti-infectives

কানাডা - ইংরেজি - Health Canada

verity pharmaceuticals inc. - fosfomycin (fosfomycin sodium) - powder for solution - 8g - fosfomycin (fosfomycin sodium) 8g - urinary anti-infectives

মাল্টা - ইংরেজি - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - linezolid - solution for infusion - linezolid 2 mg/ml - antibacterials for systemic use

মাল্টা - ইংরেজি - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - linezolid - film-coated tablet - linezolid 600 mg - antibacterials for systemic use

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - methenamine hippurate - oral tablet - 1gram

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - methenamine hippurate - oral tablet - 1gram

মাল্টা - ইংরেজি - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - daptomycin - powder for solution for injection/infusion - daptomycin 500 mg - antibacterials for systemic use

ইস্রায়েল - ইংরেজি - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - linezolid - solution for infusion - linezolid 2 mg / 1 ml - linezolid - therapy is indicated only when an organism resistant to all other antibiotics is suspected.linezolid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as:1) pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (mdrsp). 2) skin and soft tissue infections including diabetic foot infections. 3) enterococcal infections. combination therapy may be indicated if a concomitant gram negative pathogen is documented or suspected.